{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:57:45Z","timestamp":1780527465815,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jhin.2021.10.019","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T19:31:30Z","timestamp":1636227090000},"page":"9-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2"],"prefix":"10.1016","volume":"120","author":[{"given":"T.L.","family":"Meister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Todt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Banava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.H.H.","family":"Brill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pfaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2021.10.019_bib1","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s00784-020-03413-2","article-title":"Is the oral cavity relevant in SARS-CoV-2 pandemic?","volume":"24","author":"Herrera","year":"2020","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jhin.2021.10.019_bib2","article-title":"Virucidal gargling and virucidal nasal spray","volume":"16","author":"Kramer","year":"2021","journal-title":"GMS Hyg Infect Control"},{"key":"10.1016\/j.jhin.2021.10.019_bib3","series-title":"Umgang mit zahnmedizinischen Patienten bei Belastung mit Aerosol-\u00fcbertragbaren Erregern","year":"2020"},{"key":"10.1016\/j.jhin.2021.10.019_bib4","article-title":"Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection","volume":"1","author":"O'Donnell","year":"2020","journal-title":"Function"},{"key":"10.1016\/j.jhin.2021.10.019_bib5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/infdis\/jiaa471","article-title":"Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2","volume":"222","author":"Meister","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhin.2021.10.019_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab260","article-title":"Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351","author":"Meister","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhin.2021.10.019_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4265\/bio.15.45","article-title":"Evaluation of the antiviral activity of chlorine dioxide and sodium hypochlorite against feline calicivirus, human influenza virus, measles virus, canine distemper virus, human herpesvirus, human adenovirus, canine adenovirus and canine parvovirus","volume":"15","author":"Sanekata","year":"2010","journal-title":"Biocontrol Sci"},{"key":"10.1016\/j.jhin.2021.10.019_bib8","doi-asserted-by":"crossref","first-page":"L750","DOI":"10.1152\/ajplung.00552.2020","article-title":"Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures","volume":"320","author":"Sch\u00fctz","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jhin.2021.10.019_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237480","article-title":"Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in\u00a0vitro","volume":"16","author":"Morokutti-Kurz","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2021.10.019_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-12-147","article-title":"Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold","volume":"12","author":"Fazekas","year":"2012","journal-title":"BMC Complement Altern Med"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670121003832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670121003832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:19:23Z","timestamp":1759292363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670121003832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":10,"alternative-id":["S0195670121003832"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2021.10.019","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2021.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}